IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION

Juno Pharmaceuticals Corp.🇨🇦 Health Canada

Approval Id: 550484b4035d3aff
Drug Approval Canada Name: IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION
Product Name: IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION
Status: Marketed
Status Date: 2022-10-17
Original Market Date: 2019-08-29
Din: 02483394
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Inhalation
Schedule: Prescription
Ahfs: 12:12.08.12
Atc Original: R03AL02 SALBUTAMOL AND IPRATROPIUM BROMIDE
Atc Name: r 03 al 02
Aig Number: 0232902001
Company Name: Juno Pharmaceuticals Corp.
Company Address: 402, 2233 Argentia Road, Mississauga, Ontario, Canada, L5N 2X7

IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE MONOHYDRATE)

0.5 MG / 2.5 ML

SALBUTAMOL (SALBUTAMOL SULFATE)

2.5 MG / 2.5 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

550484b4035d3aff

Type

Standard